LoginSignup
Biostem Tech logo

Biostem Tech

Stock
Stock
ISIN: US0906842002
Ticker: BSEM
US0906842002
BSEM

Price

Price

Frequently asked questions

What is Biostem Tech's market capitalization?

The market capitalization of Biostem Tech is $196.65M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Biostem Tech's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Biostem Tech is 19.10. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Biostem Tech?

Biostem Tech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.63. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Biostem Tech's stock?

Currently, 0 analysts cover Biostem Tech's stock, with a consensus target price of $23.25. Analyst ratings provide insights into the stock's expected performance.

What is Biostem Tech's revenue over the trailing twelve months?

Over the trailing twelve months, Biostem Tech reported a revenue of $210.39M.

What is the EBITDA for Biostem Tech?

Biostem Tech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $20.73M. EBITDA measures the company's overall financial performance.

What is the 5-year beta of Biostem Tech's stock?

The 5-year beta for Biostem Tech is 1.46. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Biostem Tech have, and what sector and industry does it belong to?

Biostem Tech employs approximately 67 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Biostem Tech's shares?

The free float of Biostem Tech is 16.05M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $196.65M

5Y beta

 1.46

EPS (TTM)

 $0.63

Free Float

 16.05M

P/E ratio (TTM)

 19.10

Revenue (TTM)

 $210.39M

EBITDA (TTM)

 $20.73M

Pricing

52W span
$2.78$28.26

Analyst Ratings

0

Information

BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.

67

Biotechnology & Drugs

Health Care

Identifier

ISIN

US0906842002

Primary Ticker

BSEM
Join the conversation
Sign upLogin